Barry Ginsberg, M.D., Ph.D.

Dr. Barry Ginsberg is our Medical Director. Dr. Ginsberg is the Chief Executive Officer of Diabetes Technology Consultants and has over 30 years of experience in the diabetes field. He currently serves as Chairman of the Scientific Advisory Boards at SFC Fluidics and Facet Technologies, and consults with a number of companies. Prior to his time at Diabetes Technology Consultants, Dr. Ginsberg served first as the Corporate Medical Director for World Wide Diabetes Care, and then as Vice President of Worldwide Medical Affairs in the Diabetes HealthCare Division at Becton Dickinson during his 17 year tenure there. Prior, he was Principal Investigator of the Diabetes Control and Complications Trial and a Professor of Internal Medicine and Biochemistry at the University of Iowa. He also held positions as Acting Director of the Diabetes-Endocrinology Research Center, and was on the Graduate Council on Nutrition Education. He began his research in diabetes as a Fellow at the NIH in 1974, followed by clinical practice with research in the course of his 13 years at the University of Iowa. Dr. Ginsberg was a Clinical Professor of Medicine at Robert Wood Johnson College of Medicine for 14 years. He presently sits on the Editorial Board of the Journal of Diabetes Science and Technology, and is a Technical Advisor for the JDRF Artificial Pancreas Project. He has served on numerous other medical, editorial, and corporate boards. Dr. Ginsberg is well published in numerous medical journals, with almost 200 publications.

Dr. Ginsberg earned a B.A. in Chemistry, Magna Cum Laude, at Harpur College SUNY Binghamton. He also earned both an M.D. and a Ph.D. in Molecular Biology from Albert Einstein College of Medicine, Bronx, NY. He was a resident in Internal Medicine at Harvard University at Beth Israel Hospital and was a fellow in Diabetes and Endocrinology at the Diabetes Branch of National Institutes of Health.